Bank of America’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.4K | Sell |
|
|||||
|
2025
Q1 | $79.1K | Sell |
|
|||||
|
2024
Q4 | $338K | Buy |
|
|||||
|
2024
Q3 | $103K | Sell |
|
|||||
|
2024
Q2 | $56.6K | Sell |
|
|||||
|
2024
Q1 | $180K | Buy |
|
|||||
|
2023
Q4 | $125K | Sell |
|
|||||
|
2023
Q3 | $740K | Buy |
|
|||||
|
2023
Q2 | $512K | Sell |
|
|||||
|
2023
Q1 | $2.06M | Buy |
|
|||||
|
2022
Q4 | $3.5M | Buy |
|
|||||
|
2022
Q3 | $3.76M | Buy |
|
|||||
|
2022
Q2 | $2.89M | Sell |
|
|||||
|
2022
Q1 | $4.32M | Buy |
|
|||||
|
2021
Q4 | $3.21M | Sell |
|
|||||
|
2021
Q3 | $4.12M | Buy |
|
|||||
|
2021
Q2 | $4.29M | Buy |
|
|||||
|
2021
Q1 | $4.46M | Buy |
|
|||||
|
2020
Q4 | $3.95M | Sell |
|
|||||
|
2020
Q3 | $2.7M | Buy |
|
|||||
|
2020
Q2 | $2.18M | Buy |
|
|||||
|
2020
Q1 | $571K | Sell |
|
|||||
|
2019
Q4 | $920K | Sell |
|
|||||
|
2019
Q3 | $2.27M | Sell |
|
|||||
|
2019
Q2 | $3.19M | Sell |
|
|||||
|
2019
Q1 | $4.68M | Buy |
|
|||||
|
2018
Q4 | $1.83M | Buy |
|
|||||
|
2018
Q3 | $1.91M | Sell |
|
|||||
|
2018
Q2 | $3.04M | Buy |
|
|||||
|
2018
Q1 | $1.66M | Buy |
|
|||||
|
2017
Q4 | $403K | Sell |
|
|||||
|
2017
Q3 | $403K | Buy |
|
|||||
|
2017
Q2 | $154K | Sell |
|
|||||
|
2017
Q1 | $169K | Buy |
|
|||||
|
2016
Q4 | $66K | Sell |
|
|||||
|
2016
Q3 | $103K | Sell |
|
|||||
|
2016
Q2 | $169K | Buy |
|
|||||
|
2016
Q1 | $102K | Sell |
|
|||||
|
2015
Q4 | $822K | Sell |
|
|||||
|
2015
Q3 | $546K | Sell |
|
|||||
|
2015
Q2 | $1.67M | Buy |
|
|||||
|
2015
Q1 | $1.58M | Sell |
|
|||||
|
2014
Q4 | $1.7M | Sell |
|
|||||
|
2014
Q3 | $1.43M | Sell |
|
|||||
|
2014
Q2 | $2.62M | Sell |
|
|||||
|
2014
Q1 | $6.62M | Buy |
|
|||||
|
2013
Q4 | $4.47M | Buy |
|
|||||
|
2013
Q3 | $3.06M | Sell |
|
|||||
|
2013
Q2 | $2.77M | Buy |
|